InvestorsHub Logo
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Re: iclight post# 159209

Wednesday, 09/14/2016 12:04:37 PM

Wednesday, September 14, 2016 12:04:37 PM

Post# of 403254
The phantom publication for K? Disappeared the same way as B ABSSSI.. Must be the lack of funds... The next Cubist, CTIX!!!

Company Reports Successful End-of-Phase 2 Meeting With FDA

BEVERLY, MA–(Marketwired – July 20, 2015) - Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to announce that the U.S. Food and Drug Administration (FDA) has agreed to advancing brilacidin into phase 3 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News